1st Quarter - Termination

BRIGHTSPRING HEALTH SERVICES for BRIGHTSPRING HEALTH SERVICES

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$220,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Mar 31, 2026

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Termination (this page) Apr 17, 2026 $220,000 Replaced
1st Quarter - Termination Amendment Apr 17, 2026 $220,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Long-term care pharmacy and other pharmacy issues HR 5130/S 3159, IRA implementation issues included), home infusion HR 2172/S 1058, home health, home care, workforce development

LobbyistCovered position, as disclosed
ESME GREWAL —

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2172 (119th), H.R. 5130 (119th)

Pharmacy PHA

Long-term care pharmacy, IRA implementation, home infusion

LobbyistCovered position, as disclosed
ESME GREWAL —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.